Examining the Link Between a Modified Cardiometabolic Index and Cardiovascular Disease Risk in Adults with Early Cardiovascular-Kidney-Metabolic Syndrome: Findings from a Prospective Cohort Study - Report - MDSpire
Advertisement
Examining the Link Between a Modified Cardiometabolic Index and Cardiovascular Disease Risk in Adults with Early Cardiovascular-Kidney-Metabolic Syndrome: Findings from a Prospective Cohort Study
Clinical Report: Examining the Link Between a Modified Cardiometabolic Index
Overview
This study investigates the association between the modified cardiometabolic index (MCMI) and cardiovascular disease (CVD) risk among adults with early cardiovascular-kidney-metabolic syndrome. Findings indicate that MCMI is a significant predictor of CVD incidence in this population.
Background
The rising prevalence of type 2 diabetes, cardiovascular disease, and chronic kidney disease poses a significant public health challenge. These conditions are interrelated, with metabolic abnormalities serving as critical risk factors. Understanding the associations between these diseases is essential for developing effective prevention strategies.
Data Highlights
No numerical data available in the provided material.
Key Findings
MCMI is identified as an independent risk factor for CVD in patients with CKM (HR: 1.07, p = 0.006).
The study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) involving 6,953 participants.
Participants were screened for CKM syndrome stages 0–3, emphasizing the importance of early detection.
Metabolic abnormalities such as insulin resistance and inflammation are prevalent risk factors for CKD and CVD.
The AHA highlights the need for systematic screening in the preclinical phase of CKM.
Clinical Implications
Healthcare professionals should consider the MCMI as a valuable tool for assessing cardiovascular risk in patients with early CKM syndrome. Early identification and intervention may reduce the incidence of CVD in this high-risk population.
Conclusion
The findings underscore the importance of the MCMI in predicting cardiovascular risk among adults with early CKM syndrome, supporting the need for early screening and intervention strategies.
